Germany: EU could OK combined COVID vaccines next month
Germany’s health minister says European Union drug regulators may authorize the use of vaccines that are effective against two variants of the coronavirus
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Germany's health minister said Friday that European Union drug regulators may authorize the use of vaccines that are each effective against two variants of the coronavirus.
German Health Minister Karl Lauterbach said he expected the European Medicines Agency to meet Sept. 1 to consider a vaccine that would provide protection against the original virus and the omicron variant, also known as BA.1.
The EU agency would likely meet again on Sept. 27 to review a combined vaccine against the original virus and the BA.5 variant that is responsible for the latest global surge in COVID-19 cases, Lauterbach said.
Germany has procured sufficient amounts of both vaccines and would be able to start rolling them out a day after they received authorization, he said.
The U.S. Food and Drug Administration has said that combination vaccines, known as “bivalent” or “multivalent” shots, will allow boosters to retain the proven benefits of original coronavirus vaccines while providing additional protection against new variants.
Such an approach is used with flu shots, which are adjusted each year depending on the variants that are circulating and can protect against four influenza strains.
Lauterbach, a trained epidemiologist, said the potential for the coronavirus to keep mutating remained high.
“There are still very many variants that could develop,” he said, noting the large number of infections worldwide, including among people with weakened immune systems that allow the virus to persist for months.